1500 Medical Center Drive
Ann Arbor, MI 48103-5010
Available to mentor
Dr. Matuszak is the Director of Advanced Treatment Planning and supervises the research dosimetry section in the Department of Radiation Oncology. She aids in the design, implementation, and analysis of advanced adaptive therapy protocols and works extensively on in-house and national clinical trials. Dr. Matuszak has a joint appointment in the Department of Nuclear Engineering & Radiological Sciences and has active collaborations on advanced techniques for radiotherapy plan optimization within the Industrial and Operations Engineering Department. Dr. Matuszak also has current grant funding in the area of knowledge based treatment planning.
Areas of Interest:
Advanced treatment planning techniques.
Adaptive radiation therapy.
Functional avoidance treatment planning.
Knowledge-based treatment planning.
Clinical Interests:
Treatment planning.
SBRT.
Quality improvement.
Electronic charting.
-
Niraula D, Cuneo KC, Dinov ID, Gonzalez BD, Jamaluddin JB, Jin JJ, Luo Y, Matuszak MM, Ten Haken RK, Bryant AK, Dilling TJ, Dykstra MP, Frakes JM, Liveringhouse CL, Miller SR, Mills MN, Palm RF, Regan SN, Rishi A, Torres-Roca JF, Yu H-HM, El Naqa I. 2024 Apr 30;PreprintIntricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive Radiotherapy.
DOI:10.1101/2024.04.27.24306434 PMID: 38746238 -
Ramanathan S, Hochstedler KA, Laucis AM, Movsas B, Stevens CW, Kestin LL, Dominello MM, Grills IS, Matuszak M, Hayman J, Paximadis PA, Schipper MJ, Jolly S, Boike TP, Michigan Radiation Oncology Quality Consortium . Clin Lung Cancer, 2023 Dec 27;Journal ArticlePredictors of Early Hospice or Death in Patients With Inoperable Lung Cancer Treated With Curative Intent.
DOI:10.1016/j.cllc.2023.12.014 PMID: 38290875 -
Niraula D, Sun W, Jin J, Dinov ID, Cuneo K, Jamaluddin J, Matuszak MM, Luo Y, Lawrence TS, Jolly S, Ten Haken RK, El Naqa I. Sci Rep, 2023 Mar 31; 13 (1): 5279Journal ArticleA clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS).
DOI:10.1038/s41598-023-32032-6 PMID: 37002296 -
Niraula D, Jamaluddin J, Matuszak MM, Haken RKT, Naqa IE. Sci Rep, 2023 Feb 9; 13 (1): 2318Journal ArticleAuthor Correction: Quantum deep reinforcement learning for clinical decision support in oncology: application to adaptive radiotherapy.
DOI:10.1038/s41598-023-28810-x PMID: 36759642 -
Herr DJ, Wang C, Mendiratta-Lala M, Matuszak M, Mayo CS, Cao Y, Parikh ND, Ten Haken R, Owen D, Evans JR, Stanescu T, Yan M, Dawson LA, Schipper M, Lawrence TS, Cuneo KC. 2023 Oct 2;Additional ScholarshipData from A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
DOI:10.1158/1078-0432.c.6861242.v1 -
Herr DJ, Wang C, Mendiratta-Lala M, Matuszak M, Mayo CS, Cao Y, Parikh ND, Ten Haken R, Owen D, Evans JR, Stanescu T, Yan M, Dawson LA, Schipper M, Lawrence TS, Cuneo KC. 2023 Oct 2;Additional ScholarshipData from A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
DOI:10.1158/1078-0432.c.6861242 -
Herr DJ, Wang C, Mendiratta-Lala M, Matuszak M, Mayo CS, Cao Y, Parikh ND, Ten Haken R, Owen D, Evans JR, Stanescu T, Yan M, Dawson LA, Schipper M, Lawrence TS, Cuneo KC. 2023 Oct 2;Additional ScholarshipSupplementary Data 1 from A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
DOI:10.1158/1078-0432.24229190.v1 -
Herr DJ, Wang C, Mendiratta-Lala M, Matuszak M, Mayo CS, Cao Y, Parikh ND, Ten Haken R, Owen D, Evans JR, Stanescu T, Yan M, Dawson LA, Schipper M, Lawrence TS, Cuneo KC. 2023 Oct 2;Additional ScholarshipSupplementary Data 1 from A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
DOI:10.1158/1078-0432.24229190